VEA
JNCE

Virtus ETF Advisers’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Virtus ETF Advisers’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
2018
Q1 		$1.32M Buy
2017
Q4 		$344K Buy
2017
Q3 		$316K Buy
2017
Q2 		$259K Buy